TME is also hypoxic, which can down-regulate the expression of activating receptors NKG2D and induce the release of HIF1α in tumor-infiltrating NK cells, thereby reducing their antitumor response and IFN-γ production (17). The gene discussed is HIF1A; the disease is neoplasm.